Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

A Chinese male with a new genetic mutation has a skin condition and severe urinary issues, with treatments having mixed success.

A 15-year-old girl has a skin condition causing blisters on her feet, likely inherited from her family.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

HPV does not cause aggressive cancer in RDEB patients.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Focal palmoplantar callosities may help diagnose non-Herlitz junctional epidermolysis bullosa.

Children with Epidermolysis Bullosa need better access to specialized dental care.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

KLHL24-mutant stem cells help understand skin and heart disease.

Scalp hair follicle cells help protect and heal skin in certain skin conditions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

More research is needed to understand how hair keratins work and their role in hair disorders.

Keratin gene mutations cause various skin and hair disorders, but new research offers hope for future treatments.

New treatments targeting specific genes show promise for treating keratin disorders.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.